Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
or

Prophase Labs Inc (PRPH)

Prophase Labs Inc (PRPH)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.4043 -0.0357 (-8.11%) 03/31/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.4039 -0.0004 (-0.10%) 19:56 ET
Quote Overview for Mon, Mar 31st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.3520
Day High
0.4400
Open 0.3900
Previous Close 0.4400 0.4400
Volume 1,085,000 1,085,000
Avg Vol 1,867,965 1,867,965
Stochastic %K 44.01% 44.01%
Weighted Alpha -87.64 -87.64
5-Day Change -0.0250 (-5.82%) -0.0250 (-5.82%)
52-Week Range 0.2179 - 7.4800 0.2179 - 7.4800
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,505
  • Shares Outstanding, K 23,874
  • Annual Sales, $ 44,380 K
  • Annual Income, $ -16,780 K
  • EBIT $ -35 M
  • EBITDA $ -29 M
  • 60-Month Beta -0.53
  • Price/Sales 0.58
  • Price/Cash Flow N/A
  • Price/Book 0.23
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.26
  • Most Recent Earnings $-0.35 on 11/13/24
  • Next Earnings Date 03/31/25 [BMO]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Options Overview Details

View History
  • Implied Volatility 367.45% ( +59.51%)
  • Historical Volatility 195.93%
  • IV Percentile 72%
  • IV Rank 29.92%
  • IV High 1,158.78% on 02/11/25
  • IV Low 29.66% on 10/18/24
  • Put/Call Vol Ratio 0.03
  • Today's Volume 104
  • Volume Avg (30-Day) 49
  • Put/Call OI Ratio 0.05
  • Today's Open Interest 2,786
  • Open Int (30-Day) 2,857

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3088 +30.93%
on 03/21/25
Period Open: 0.4488
0.5950 -32.05%
on 03/25/25
-0.0445 (-9.92%)
since 02/28/25
3-Month
0.2179 +85.54%
on 02/03/25
Period Open: 0.6370
0.9349 -56.75%
on 01/03/25
-0.2327 (-36.53%)
since 12/27/24
52-Week
0.2179 +85.54%
on 02/03/25
Period Open: 6.4700
7.4800 -94.59%
on 04/16/24
-6.0657 (-93.75%)
since 03/28/24

Most Recent Stories

More News
ProPhase Labs, Inc. Announces Financial Results for the Year Ended December 31, 2024

PRPH : 0.4043 (-8.11%)
ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025

PRPH : 0.4043 (-8.11%)
Q1 Virtual Investor Summit: On-Demand Presentations Now Live

NEW YORK, NY / ACCESS Newswire / March 18, 2025 / The Investor Summit is excited to announce that presentations from Q1 Investor Summit are now available for on-demand viewing. Attendees and investors...

SNANF : 0.1900 (unch)
BRNS : 0.9727 (-7.36%)
FEMY : 1.2500 (-3.10%)
PERF : 1.8700 (+10.65%)
DRTS : 2.51 (-1.95%)
GIFT : 2.00 (-7.83%)
ROYIF : 0.0202 (-51.21%)
ZCAR : 5.01 (+21.45%)
CLNN : 3.08 (-4.35%)
MIND : 6.00 (+1.87%)
PYPD : 2.71 (-1.09%)
TOVX : 1.1000 (-3.51%)
ProPhase Labs to Present at the Investor Summit Virtual on March 11

PRPH : 0.4043 (-8.11%)
ProPhase Labs Examines Strategic Opportunities to Leverage Its DTC Multi-Media Infrastructure with Telehealth Physician Networks for Prescription Drugs

PRPH : 0.4043 (-8.11%)
ProPhase Labs Announces Excellent Progress with Crown Medical Collections Targeting Over $50 Million in Net Near-Term Cash Recovery from COVID-19 Receivables

PRPH : 0.4043 (-8.11%)
ProPhase Labs hires Stuart Hollenshead as COO, the former COO and CBO of Barstool Sports

PRPH : 0.4043 (-8.11%)
ProPhase Labs Announces Closing of $23.6 Million Sale of Pharmaloz Manufacturing to Houston-Based Private Equity Firm

PRPH : 0.4043 (-8.11%)
ProPhase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Adds Seasoned Industry Expert, and Plans Significant Cost-Cutting Measures

PRPH : 0.4043 (-8.11%)
ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2024

PRPH : 0.4043 (-8.11%)

Business Summary

ProPhase Labs, Inc., formerly known as The Quigley Corporation, is a manufacturer, marketer and distributor of a diversified range of homeopathic and health products that are offered to the general public. The Company's mission is to develop and market natural health care pharmaceuticals and nutriceuticals...

See More

Key Turning Points

3rd Resistance Point 0.5335
2nd Resistance Point 0.4868
1st Resistance Point 0.4455
Last Price 0.4043
1st Support Level 0.3575
2nd Support Level 0.3108
3rd Support Level 0.2695

See More

52-Week High 7.4800
Fibonacci 61.8% 4.7059
Fibonacci 50% 3.8489
Fibonacci 38.2% 2.9920
Last Price 0.4043
52-Week Low 0.2179

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies